FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years."

  Health   Aug 11, 2024   0   28  Add to Reading List
FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years."
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow